# A Study in Healthy Men to Test How BI 474121 is Tolerated

> **NCT04964453** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** BI 474121

## Key facts

- **NCT ID:** NCT04964453
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-21
- **Primary completion:** 2021-11-11
- **Final completion:** 2021-11-16
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04964453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04964453, "A Study in Healthy Men to Test How BI 474121 is Tolerated". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04964453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*